Molecular Diagnostics Market - Forecast(2022 - 2027)

Report Code: HCR 0068 Report Format: PDF + Excel

Molecular Diagnostics Market Overview

The Molecular Diagnostics Market size is estimated to reach $25.3 billion by 2027, growing at a CAGR of 8.6% during the forecast period 2022-2027. Molecular diagnostics can be demarcated as a group of techniques proficient in identifying specific genetic disparities in patients by using diverse technologies such as polymerase chain reaction, single nucleotide polymorphisms, electrophoresis, isothermal nucleic acid amplification technology, mass spectrometry to scrutinize biomarkers in the genome. Molecular diagnostics allows doctors to select an unsurpassed form of therapy by supporting the detection of maladies and possible risks. Moreover, it helps medical professionals to chart individualized or customer-specific plans. Therefore, accurate prescription and treatment duration help patients circumvent lengthy recapitulations of pointless drugs being used on patients recurrently with hostile effects. Besides cancer monitoring, molecular diagnostic can be used to manage infections like methicillin-resistant staphylococcus. Nevertheless, rising incidences of infections and cancer, augmenting health attentiveness among people, hiking demand for personalized medicines, and enlarging research and developmental activities are the factors set to drive the growth of the Molecular Diagnostics Industry for the period 2022-2027.

Report Coverage

The report: “Molecular Diagnostics Market Forecast (2022-2027)” by Industry ARC covers an in-depth analysis of the following segments of the Molecular Diagnostics Market.

By Product: Reagents, Instrument, and other devices.
By Application: Leukocyte Antigen Typing, Oncology, Blood screening, Transferrable ailments, and Others.
By Technology: TMA, In Situ Hybridization, PCR, DNA sequencing, INAAT, and Others.
By End User: Hospitals, Laboratories, CROs, and Other medical facilities.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

  • Geographically, North America’s Molecular Diagnostics Market accounted for the highest revenue share in 2021. The growth is owing to full-fledged healthcare infrastructure, the presence of top-notch pharmacy and biopharmaceutical companies, and the high disposable income of people. Furthermore, Asia-Pacific is poised to offer lucrative growth opportunities over the forecast period owing to rising disposable incomes and the higher class of the geriatric population, among many other reasons.
  • Intensifying cancer cases are said to be the preeminent driver driving the growth of the Molecular Diagnostics Market. The exorbitant cost of the associated treatments and instruments is said to reduce the market growth.
  • Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Molecular Diagnostics Market report.

Molecular Diagnostics Market- Geography (%) for 2021.

Molecular Diagnostics Market

For More Details on This Report - Request for Sample

Molecular Diagnostics Market Segment Analysis - By Technology

The Molecular Diagnostics Market based on technology can be further segmented into TMA, In Situ Hybridization, PCR, DNA sequencing, INAAT, and Others. The polymerase chain reaction (PCR) segment held the largest share in 2021. The growth is owing to an upsurge in COVID-19 cases throughout the world. The escalating infection rate has resulted in the gigantic use of RT-PCR testing in order to annihilate the virus. In addition to that, across-the-board accessibility, easy-to-use nature, and high meticulousness provide fairgrounds for the growth prospects.

Additionally, the PCR (polymerase chain reaction) segment is estimated to be the fastest-growing segment, with a CAGR of 9.3% over the period 2022-2027. This growth is owing to the low-price equivalent to other diagnostic procedures, along with its reasonable accuracy. In addition to that, snowballing health attentiveness has subjected people to prioritize prevention over treatment.

Molecular Diagnostics Market Segment Analysis - By End User

The Molecular Diagnostics Market, based on the end-user, can be further segmented into hospitals, laboratories, CROs, and Other medical facilities. The hospital segment held the largest share in 2021. The growth is owing to technological advancements in tools and techniques required in the diagnosis process. Moreover, the inclusive presence of hospitals in both urban and rural areas, quick adoption of the latest tools and techniques, and top-of-the-line medical professionals are the factor of growth. On the other hand, proliferating emergence of private hospitals is another factor providing growth opportunities.

Nevertheless, the hospitals and research laboratories segment are estimated to be the fastest-growing, with a CAGR of 9.5% over the forecast period 2022-2027. This growth is owing to augmenting hospitalizations as the world is reeling under catastrophes like cancer and COVID-19. On the other hand, heightening research spending by governments and private players to better prepare for future contingencies provides reasonable reasons for the growth prospects.

Molecular Diagnostics Market Segment Analysis -By Geography

The Molecular Diagnostics Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share, with 38% of the overall market in 2021. The growth in this segment is owing to the factors such as growing chronic illnesses like cancer and up-to-date healthcare infrastructure. Besides being the biggest healthcare spender, the U.S. has one of the best research and academic institutions like MIT, Harvard, and Stanford, which substantially provide literature and research studies augmenting a better product and service market. On the other hand, ample research and medical professionals, health-conscious public, and high disposable incomes are the factors providing growth prospects. However, Asia-Pacific is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to a high prevalence of infectious maladies because of poor hygiene. Likewise, the broadening geriatric population, bettering healthcare infrastructure as governments are rectifying the finances, and changing lifestyles of people with mounting economic prosperity are driving the demand for the molecular diagnostics market.

Molecular Diagnostics Market Drivers

Boosting prevalence of chronic ailments like cancer is anticipated to boost market demand.

Owing to rapid mechanization, the concept of manual work has evaporated from people’s lives. Therefore, owing to sedentary lifestyles along with poor ingestion habits, needle-stick diseases like cancer have come to the forefront in both the developed and developing world. According to a WHO report, nearly 10 million people fell victim to cancer in 2021 and lost their lives. Out of which, around 1.9 million were reported in the U.S. On the other hand, the surge in infections and transferable maladies has its share in heightened demand for molecular diagnostics. Kidney disease, respiratory infections, and chronic obstructive pulmonary disease are common examples. According to a report, approximately 37 million people in the U.S. will have CKD in 2021. The prevalence of such diseases is likely to reach epidemic proportions as the global old-age population is anticipated to cross 2 billion before long.

Modernizing healthcare infrastructure and spending are expected to boost market demand.

In the wake of the overwhelming burden that the pandemic has laid on the healthcare sector, governments worldwide have started to expand their healthcare spending. With staggering spending of over $4 trillion, the U.S. is the most significant healthcare spender compared to any other country. Moreover, the overall American healthcare spending is likely to reach $6.2 trillion by 2028. Moreover, with a spike of 12.6 percent in 2020, the Chinese healthcare expenditure reached $926.8 billion, whereas its total public healthcare spending crossed 1.9 trillion yuan in 2021. Nevertheless, countries like India are doing everything to ameliorate existing healthcare infrastructure.

Molecular Diagnostics Market Challenges

Exorbitant initial installation costs are anticipated to hamper the market growth.

The cost of setting up a facility with state-of-the-art technologies like FISH, NGS, and others is on the higher side. Millions of dollars are required to invest in procuring the necessary machinery, building the facility, and hiring professionals with an adequate amount of knowledge. On the other hand, the cost of the treatment is a bit costly for people in low-income countries, which can pose a real challenge to the sturdy growth of the market. A triple quadrupole mass spectrometer costs about $350,000, depending on the type of features it comes with. A high-resolution time-of-flight instrument can run $350,000 to $400,000. An Orbitrap extended-mass-range model costs anywhere from $400,000 to $800,000, thereby invigorating higher capital requirements.

Molecular Diagnostics Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Market. Molecular Diagnostics market top 10 companies include-

  1. Qiagen
  2. Abbott laboratories
  3. Roche Diagnostics
  4. Hologic Inc.
  5. Danaher Corporation
  6. Siemens Healthcare
  7. Novartis International AG
  8. Grifols S.A.
  9. Becton, Dickinson and Company
  10. BioMerieux SA

Recent Developments

  • On December 1, 2021, Massachusetts, United States-based renowned medical technology company “Hologic” announced that it had successfully acquired a Colorado-based surgical device company, “Bolder Surgical,” A payment of $160 million was made to conclude the acquisition process. The transaction has boosted Hologic’s laparoscopic portfolio.
  • On May 1, 2021, Basel, Switzerland-based Roche (a leading biotech firm famous for its infectious disease and oncology drugs) announced the successful acquisition of California, United States-based company GenMark Diagnostics. The total value of the transaction stands at around $1.8 billion. The acquisition has strengthened its syndromic testing and molecular diagnostic portfolio of Roche.
  • On January 6, 2020, Basel, Switzerland-based renowned pharmaceutical manufacturer “Novartis AG” publicized that it had successfully added Inclisiran (a cholesterol controlling therapy) to its portfolio with the acquisition of New Jersey, United States-based The Medicine Company (a firm that deals in acute care treatments). A staggering payment of $9.7 billion was made to bring the acquisition to a close.

Relevant Links:

Ischemic Stroke Diagnostic Equipment Market – Forecast (2022 - 2027)

Report Code: HCR 1269

Molecular Oncology Market – Forecast (2022 - 2027)

Report Code: HCR 1468

Cancer Biomarkers Market-Forecast (2022 – 2027)

Report Code: HCR 0194

For more Lifesciences and Healthcare Market reports, please click here

1. Molecular Diagnostics Market Overview
    1.1 Definitions and Scope
2. Molecular Diagnostics Market- Executive Summary
3. Molecular Diagnostics Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Molecular Diagnostics Market – Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Molecular Diagnostics Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Molecular Diagnostics Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Molecular Diagnostics Market – By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Molecular Diagnostics Market- By Product (Market Size –$Million/$Billion) 
    8.1 Reagents
    8.2 Instrument
    8.3 Others
9. Molecular Diagnostics Market- By Application (Market Size –$Million/$Billion) 
    9.1 Leukocyte Antigen Testing
    9.2 Oncology
    9.3 Blood Screening
    9.4 Transferrable Ailments
    9.5 Others
10. Molecular Diagnostics Market- By Technology (Market Size –$Million/$Billion) 
    10.1 TMA
    10.2 In-Situ Hybridization
    10.3 PCR
    10.4 DNA Sequencing
    10.5 INAAT
    10.6 Others
11. Molecular Diagnostics Market- End-Use (Market Size –$Million/$Billion) 
    11.1 Food Processing
    11.2 Nutraceuticals
    11.3 Beverages
    11.4 Dietary Supplements
    11.5 Others
12. Molecular Diagnostics Market - By Geography (Market Size -$Million/Billion)
    12.1 North America
        12.1.1    U.S
        12.1.2    Canada
        12.1.3    Mexico
    12.2 Europe
        12.2.1 Germany
        12.2.2 France
        12.2.3 UK
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 Japan
        12.3.3 South Korea
        12.3.4 India
        12.3.5 Australia & New Zealand
        12.3.6 Rest of APAC
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Chile
        12.4.4 Colombia
        12.4.5 Rest of South America
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. Molecular Diagnostics Market - Market Entropy
    13.1 New product launches
    13.2 M&A's, collaborations, JVs and partnerships
14. Molecular Diagnostics Market – Industry Competition Landscape (Premium)
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key Companies
        14.1.3 Market Share by Countries – Key Companies
    14.2 Competition Matrix
    14.3 Best Practices for Companies
15. Molecular Diagnostics Market – Key Company List by Country Premium (Premium)
16. Molecular Diagnostics Market - Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies*"
List of Tables

Table 1: Molecular Diagnostics Market Overview 2021-2026
Table 2: Molecular Diagnostics Market Leader Analysis 2018-2019 (US$)
Table 3: Molecular Diagnostics Market Product Analysis 2018-2019 (US$)
Table 4: Molecular Diagnostics Market End User Analysis 2018-2019 (US$)
Table 5: Molecular Diagnostics Market Patent Analysis 2013-2018* (US$)
Table 6: Molecular Diagnostics Market Financial Analysis 2018-2019 (US$)
Table 7: Molecular Diagnostics Market Driver Analysis 2018-2019 (US$)
Table 8: Molecular Diagnostics Market Challenges Analysis 2018-2019 (US$)
Table 9: Molecular Diagnostics Market Constraint Analysis 2018-2019 (US$)
Table 10: Molecular Diagnostics Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Molecular Diagnostics Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Molecular Diagnostics Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Molecular Diagnostics Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Molecular Diagnostics Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Molecular Diagnostics Market Value Chain Analysis 2018-2019 (US$)
Table 16: Molecular Diagnostics Market Pricing Analysis 2021-2026 (US$)
Table 17: Molecular Diagnostics Market Opportunities Analysis 2021-2026 (US$)
Table 18: Molecular Diagnostics Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Molecular Diagnostics Market Supplier Analysis 2018-2019 (US$)
Table 20: Molecular Diagnostics Market Distributor Analysis 2018-2019 (US$)
Table 21: Molecular Diagnostics Market Trend Analysis 2018-2019 (US$)
Table 22: Molecular Diagnostics Market Size 2018 (US$)
Table 23: Molecular Diagnostics Market Forecast Analysis 2021-2026 (US$)
Table 24: Molecular Diagnostics Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Molecular Diagnostics Market, Revenue & Volume, By Products, 2021-2026 ($)
Table 26: Molecular Diagnostics Market By Products, Revenue & Volume, By Analyzers, 2021-2026 ($)
Table 27: Molecular Diagnostics Market By Products, Revenue & Volume, By Reagents, 2021-2026 ($)
Table 28: Molecular Diagnostics Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 29: Molecular Diagnostics Market By Technology, Revenue & Volume, By PCR, 2021-2026 ($)
Table 30: Molecular Diagnostics Market By Technology, Revenue & Volume, By INAAT, 2021-2026 ($)
Table 31: Molecular Diagnostics Market By Technology, Revenue & Volume, By Hybridization, 2021-2026 ($)
Table 32: Molecular Diagnostics Market By Technology, Revenue & Volume, By DNA Sequencing and Next Generation Sequencing, 2021-2026 ($)
Table 33: Molecular Diagnostics Market By Technology, Revenue & Volume, By Spectral Karyotype Imaging, 2021-2026 ($)
Table 34: Molecular Diagnostics Market, Revenue & Volume, By Applications, 2021-2026 ($)
Table 35: Molecular Diagnostics Market By Applications, Revenue & Volume, By Infectious Disease, 2021-2026 ($)
Table 36: Molecular Diagnostics Market By Applications, Revenue & Volume, By Oncology, 2021-2026 ($)
Table 37: Molecular Diagnostics Market By Applications, Revenue & Volume, By Genetic Disease Screening, 2021-2026 ($)
Table 38: Molecular Diagnostics Market By Applications, Revenue & Volume, By Blood Screening, 2021-2026 ($)
Table 39: Molecular Diagnostics Market By Applications, Revenue & Volume, By Microbiology, 2021-2026 ($)
Table 40: Molecular Diagnostics Market, Revenue & Volume, By End Users, 2021-2026 ($)
Table 41: Molecular Diagnostics Market By End Users, Revenue & Volume, By Hospitals, 2021-2026 ($)
Table 42: Molecular Diagnostics Market By End Users, Revenue & Volume, By Clinical Laboratories, 2021-2026 ($)
Table 43: Molecular Diagnostics Market By End Users, Revenue & Volume, By Academics, 2021-2026 ($)
Table 44: North America Molecular Diagnostics Market, Revenue & Volume, By Products, 2021-2026 ($)
Table 45: North America Molecular Diagnostics Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 46: North America Molecular Diagnostics Market, Revenue & Volume, By Applications, 2021-2026 ($)
Table 47: North America Molecular Diagnostics Market, Revenue & Volume, By End Users, 2021-2026 ($)
Table 48: South america Molecular Diagnostics Market, Revenue & Volume, By Products, 2021-2026 ($)
Table 49: South america Molecular Diagnostics Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 50: South america Molecular Diagnostics Market, Revenue & Volume, By Applications, 2021-2026 ($)
Table 51: South america Molecular Diagnostics Market, Revenue & Volume, By End Users, 2021-2026 ($)
Table 52: Europe Molecular Diagnostics Market, Revenue & Volume, By Products, 2021-2026 ($)
Table 53: Europe Molecular Diagnostics Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 54: Europe Molecular Diagnostics Market, Revenue & Volume, By Applications, 2021-2026 ($)
Table 55: Europe Molecular Diagnostics Market, Revenue & Volume, By End Users, 2021-2026 ($)
Table 56: APAC Molecular Diagnostics Market, Revenue & Volume, By Products, 2021-2026 ($)
Table 57: APAC Molecular Diagnostics Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 58: APAC Molecular Diagnostics Market, Revenue & Volume, By Applications, 2021-2026 ($)
Table 59: APAC Molecular Diagnostics Market, Revenue & Volume, By End Users, 2021-2026 ($)
Table 60: Middle East & Africa Molecular Diagnostics Market, Revenue & Volume, By Products, 2021-2026 ($)
Table 61: Middle East & Africa Molecular Diagnostics Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 62: Middle East & Africa Molecular Diagnostics Market, Revenue & Volume, By Applications, 2021-2026 ($)
Table 63: Middle East & Africa Molecular Diagnostics Market, Revenue & Volume, By End Users, 2021-2026 ($)
Table 64: Russia Molecular Diagnostics Market, Revenue & Volume, By Products, 2021-2026 ($)
Table 65: Russia Molecular Diagnostics Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 66: Russia Molecular Diagnostics Market, Revenue & Volume, By Applications, 2021-2026 ($)
Table 67: Russia Molecular Diagnostics Market, Revenue & Volume, By End Users, 2021-2026 ($)
Table 68: Israel Molecular Diagnostics Market, Revenue & Volume, By Products, 2021-2026 ($)
Table 69: Israel Molecular Diagnostics Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 70: Israel Molecular Diagnostics Market, Revenue & Volume, By Applications, 2021-2026 ($)
Table 71: Israel Molecular Diagnostics Market, Revenue & Volume, By End Users, 2021-2026 ($)
Table 72: Top Companies 2018 (US$)Molecular Diagnostics Market, Revenue & Volume
Table 73: Product Launch 2018-2019Molecular Diagnostics Market, Revenue & Volume
Table 74: Mergers & Acquistions 2018-2019Molecular Diagnostics Market, Revenue & Volume


List of Figures

Figure 1: Overview of Molecular Diagnostics Market 2021-2026
Figure 2: Market Share Analysis for Molecular Diagnostics Market 2018 (US$)
Figure 3: Product Comparison in Molecular Diagnostics Market 2018-2019 (US$)
Figure 4: End User Profile for Molecular Diagnostics Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Molecular Diagnostics Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Molecular Diagnostics Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Molecular Diagnostics Market 2018-2019
Figure 8: Ecosystem Analysis in Molecular Diagnostics Market 2018
Figure 9: Average Selling Price in Molecular Diagnostics Market 2021-2026
Figure 10: Top Opportunites in Molecular Diagnostics Market 2018-2019
Figure 11: Market Life Cycle Analysis in Molecular Diagnostics Market
Figure 12: GlobalBy ProductsMolecular Diagnostics Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy TechnologyMolecular Diagnostics Market Revenue, 2021-2026 ($)
Figure 14: GlobalBy ApplicationsMolecular Diagnostics Market Revenue, 2021-2026 ($)
Figure 15: GlobalBy End UsersMolecular Diagnostics Market Revenue, 2021-2026 ($)
Figure 16: Global Molecular Diagnostics Market - By Geography
Figure 17: Global Molecular Diagnostics Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 18: Global Molecular Diagnostics Market CAGR, By Geography, 2021-2026 (%)
Figure 19: North America Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 20: US Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 21: US GDP and Population, 2018-2019 ($)
Figure 22: US GDP – Composition of 2018, By Sector of Origin
Figure 23: US Export and Import Value & Volume, 2018-2019 ($)
Figure 24: Canada Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 25: Canada GDP and Population, 2018-2019 ($)
Figure 26: Canada GDP – Composition of 2018, By Sector of Origin
Figure 27: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 28: Mexico Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 29: Mexico GDP and Population, 2018-2019 ($)
Figure 30: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 31: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 32: South America Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 33: Brazil Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 34: Brazil GDP and Population, 2018-2019 ($)
Figure 35: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 36: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 37: Venezuela Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 38: Venezuela GDP and Population, 2018-2019 ($)
Figure 39: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 40: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 41: Argentina Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 42: Argentina GDP and Population, 2018-2019 ($)
Figure 43: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 44: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 45: Ecuador Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 46: Ecuador GDP and Population, 2018-2019 ($)
Figure 47: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 48: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 49: Peru Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 50: Peru GDP and Population, 2018-2019 ($)
Figure 51: Peru GDP – Composition of 2018, By Sector of Origin
Figure 52: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 53: Colombia Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 54: Colombia GDP and Population, 2018-2019 ($)
Figure 55: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 56: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 57: Costa Rica Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 58: Costa Rica GDP and Population, 2018-2019 ($)
Figure 59: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 60: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 61: Europe Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 62: U.K Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 63: U.K GDP and Population, 2018-2019 ($)
Figure 64: U.K GDP – Composition of 2018, By Sector of Origin
Figure 65: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 66: Germany Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 67: Germany GDP and Population, 2018-2019 ($)
Figure 68: Germany GDP – Composition of 2018, By Sector of Origin
Figure 69: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 70: Italy Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 71: Italy GDP and Population, 2018-2019 ($)
Figure 72: Italy GDP – Composition of 2018, By Sector of Origin
Figure 73: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 74: France Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 75: France GDP and Population, 2018-2019 ($)
Figure 76: France GDP – Composition of 2018, By Sector of Origin
Figure 77: France Export and Import Value & Volume, 2018-2019 ($)
Figure 78: Netherlands Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 79: Netherlands GDP and Population, 2018-2019 ($)
Figure 80: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 81: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 82: Belgium Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 83: Belgium GDP and Population, 2018-2019 ($)
Figure 84: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 85: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 86: Spain Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 87: Spain GDP and Population, 2018-2019 ($)
Figure 88: Spain GDP – Composition of 2018, By Sector of Origin
Figure 89: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 90: Denmark Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 91: Denmark GDP and Population, 2018-2019 ($)
Figure 92: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 93: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 94: APAC Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 95: China Molecular Diagnostics Market Value & Volume, 2021-2026
Figure 96: China GDP and Population, 2018-2019 ($)
Figure 97: China GDP – Composition of 2018, By Sector of Origin
Figure 98: China Export and Import Value & Volume, 2018-2019 ($)Molecular Diagnostics Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 99: Australia Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 100: Australia GDP and Population, 2018-2019 ($)
Figure 101: Australia GDP – Composition of 2018, By Sector of Origin
Figure 102: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 103: South Korea Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 104: South Korea GDP and Population, 2018-2019 ($)
Figure 105: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 106: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 107: India Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 108: India GDP and Population, 2018-2019 ($)
Figure 109: India GDP – Composition of 2018, By Sector of Origin
Figure 110: India Export and Import Value & Volume, 2018-2019 ($)
Figure 111: Taiwan Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 112: Taiwan GDP and Population, 2018-2019 ($)
Figure 113: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 114: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 115: Malaysia Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 116: Malaysia GDP and Population, 2018-2019 ($)
Figure 117: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 118: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 119: Hong Kong Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 120: Hong Kong GDP and Population, 2018-2019 ($)
Figure 121: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 122: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 123: Middle East & Africa Molecular Diagnostics Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 124: Russia Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 125: Russia GDP and Population, 2018-2019 ($)
Figure 126: Russia GDP – Composition of 2018, By Sector of Origin
Figure 127: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 128: Israel Molecular Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 129: Israel GDP and Population, 2018-2019 ($)
Figure 130: Israel GDP – Composition of 2018, By Sector of Origin
Figure 131: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 132: Entropy Share, By Strategies, 2018-2019* (%)Molecular Diagnostics Market
Figure 133: Developments, 2018-2019*Molecular Diagnostics Market
Figure 134: Company 1 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 1 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 1 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 2 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 2 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 2 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 3 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 3 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 3 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 4 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 4 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 4 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 5 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 5 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 5 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 6 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 6 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 6 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 7 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 7 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 7 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 8 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 8 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 8 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 9 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 9 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 9 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 10 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 10 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 10 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 11 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 11 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 11 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 12 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 12 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 12 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 13 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 13 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 13 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 14 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 14 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 14 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 176: Company 15 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 177: Company 15 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 178: Company 15 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)